Choroidal Thickness in Glaucoma Patients and Healthy Controls

University of Zurich (UZH)

Status: Unknown

Conditions: Glaucoma Patients and Healthy Controls

Treatments: Device: Spectralis® SD-OCT, Heidelberg Engineering GmbH, H

Study type: Observational

Funder types: Other

Identifiers

NCT01293474

EDI-OCT

Details and patient eligibility

About

With the new software tool (EDI, enhanced depth imaging) of the Spectralis® spectral-domain optical coherence tomography (SD-OCT) it is possible to visualize and measure the choroidal thickness. In glaucoma a vascular component is known. Therefore a difference of choroidal thickness in glaucoma patients and healthy controls is proposed.

• Trial with medical device

Enrollment: 200 estimated patients

Sex: All

Ages: 50+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria: for both groups (glaucoma study group and control group):

men and women of at least 50 years of age

for the glaucoma study group: diagnosis of primary open angle glaucoma (POAG)

Exclusion criteria: for both groups (glaucoma study group and control group):

• less then 50 years of age
• any pathology of the central retina
• any optic nerve disorder other then glaucoma
• retinal vascular disorder

for the glaucoma study group: other glaucoma diagnosis then primary open angle glaucoma

for the control group: any diagnosis of glaucoma

Trial design

200 participants in 2 patient groups

glaucoma patients

Description:

patients with diagnosis of primary open angle glaucoma

Treatment:

Device: Spectralis® SD-OCT, Heidelberg Engineering GmbH, H

control group

Description:

age matched healthy controls

Treatment:

Device: Spectralis® SD-OCT, Heidelberg Engineering GmbH, H